Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.

[1]  B. Gusterson,et al.  High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  T. Hickish,et al.  A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). , 1994, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  D. Talbot,et al.  Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  D. Talbot,et al.  Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  E. Adrover,et al.  Carboplatin: an active drug in metastatic breast cancer. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  I. Judson,et al.  A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer. , 1991, British Journal of Cancer.

[7]  I. Smith,et al.  A randomised comparative trial of mitozantrone/methotrexate/mitomycin C (MMM) and cyclophosphamide/methotrexate/5 FU (CMF) in the treatment of advanced breast cancer. , 1991, British Journal of Cancer.

[8]  R. Hansen,et al.  5-Fluorouracil by protracted venous infusion: a review of recent clinical studies. , 1991, Cancer investigation.

[9]  J. Bitran,et al.  Platinol (CDDP) and continuous intravenous infusion 5-fluorouracil in refractory stage IV breast cancer: a phase II study. , 1990, Cancer investigation.

[10]  E Wiltshaw,et al.  Carboplatin dosage: prospective evaluation of a simple formula based on renal function. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  O. F. Hidalgo,et al.  120 Hours Simultaneous Infusion of Cisplatin and Fluorouracil in Metastatic Breast Cancer , 1989, American journal of clinical oncology.

[12]  G. Sledge,et al.  Cisplatin in the management of breast cancer. , 1989, Seminars in oncology.

[13]  R. Pazdur,et al.  Low‐dose continuous infusion 5‐fluorouracil. Evaluation in advanced breast carcinoma , 1989, Cancer.

[14]  G. Bonadonna,et al.  Chemotherapy of Advanced Disease , 1989 .

[15]  G. Sledge,et al.  Cisplatin as first-line therapy for metastatic breast cancer. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Tattersall,et al.  Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. , 1987, The New England journal of medicine.

[17]  A. Korzun,et al.  Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  A. Korzun,et al.  Chemotherapy Versus Chemoimmunotherapy (CAF v CAFVP v CMF Each t MER) for Metastatic Carcinoma of the Breast: A CALGB Study , 1987 .

[19]  R. Gelman,et al.  The eastern cooperative oncology group experience with cyclophosphamide, adriamycin, and 5‐fluorouracil (CAF) in patients with metastatic breast cancer , 1985, Cancer.

[20]  R. Gelman,et al.  Comparison of CAF versus CMFP in metastatic breast cancer: analysis of prognostic factors. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  P. Band,et al.  Comparison of induction chemotherapies for metastatic breast cancer. An eastern cooperative oncology group trial , 1982, Cancer.

[22]  M. Palmer,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1982, British Journal of Cancer.

[23]  J. Lokich,et al.  Phase I study of protracted venous infusion of 5‐fluorouracil , 1981, Cancer.

[24]  D. Carr.  The manual for the staging of cancer. , 1977, Annals of internal medicine.

[25]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.

[26]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .